1887

Abstract

SUMMARY

The morphological responses of to N-formimidoyl thienamycin, azthreonam, ceftazidime and cefoperazone were studied by transmission electron microscopy. They were correlated with the results of viable counts and continuous turbidimetric monitoring. N-formimidoyl thienamycin initially caused the formation of abnormally shaped cells which developed into spheroplasts. The other antibiotics caused filamentation of the bacteria, which subsequently underwent lysis. The degree and mechanism of lysis varied between the antibiotics. Exposure to azthreonam also resulted in the deposition of electron-dense intracellular material. As judged by conventional minimum-inhibitory-concentration tests, all the agents exhibited similar activity against the strains of tested, with ceftazidime displaying the highest activity. However, N-formimidoyl thienamycin caused the most extensive morphological damage and resulted in the most rapid fall in viable count.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-17-2-159
1984-04-01
2022-05-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/17/2/medmicro-17-2-159.html?itemId=/content/journal/jmm/10.1099/00222615-17-2-159&mimeType=html&fmt=ahah

References

  1. Chase H. A., Fuller C., Reynolds P. 1981; The role of penicillin-binding proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium. European Journal of Biochemistry 117:301–310
    [Google Scholar]
  2. Elliott T. S. J., Greenwood D. 1983; The response of Pseudomononas aeruginosa to azlocillin, ticarcillin and cefsulodin. Journal of Medical Microbiology 16:351–362
    [Google Scholar]
  3. Greenwood D., O’Grady F. 1973; Comparison of the response of Escherichia coli and Proteus mirabilis to seven β-lactam antibiotics. Journal of Infectious Diseases 128:211–222
    [Google Scholar]
  4. Greenwood D., Eley A. 1982; Comparative antipseudomonal activity of some newer β-actam agents. Antimicrobial Agents and Chemotherapy 21:204–209
    [Google Scholar]
  5. Jacobus N. V., Ferreira M. C., Barza M. 1982; In vitro activity of azthreonam, a monobactam antibiotic. Antimicrobial Agents and Chemotherapy 22:832–838
    [Google Scholar]
  6. Kayser F. H., Huf E., Homberger F. 1981; The microbiology of cefoperazone. Infection. 9: Suppl 1S6–S12
    [Google Scholar]
  7. Livermore D. M., Williams J. D. 1981; In-vitro activity of the monobactam, SQ 26, 776, against gram-negative bacteria and its stability to their β-lactam. Journal of Antimicrobial Chemotherapy 8: Suppl E29–37
    [Google Scholar]
  8. Mackintosh I. P., O’Grady F., Greenwood D., Watson B. W., Crichton T. C., Piper R., Ferrer A. 1973; A twelve channel bacterial growth monitoring system. Biomedical Engineering 8:514–515–526
    [Google Scholar]
  9. Mollenhauer H. H. 1964; Plastic embedding mixtures for use in electron microscopy. Stain Technology 39:111
    [Google Scholar]
  10. Phillips I., Warren C., Shannon K., King A., Flanslo D. 1981; Ceftazidime: in-vitro antibacterial activity and susceptibility to β-actamases compared with that of cefotaxime, moxalactam and other β-actam antibiotics. Journal of Antimicrobial Chemotherapy 8: Suppl B23–31
    [Google Scholar]
  11. Richmond M. H. 1980; Resistance of Pseudomonas aeruginosa to antibiotics. In Pseudomonas aeruginosa the organism, diseases it causes and their treatment, edited by Sabath L. D. Hans Huber; Bern: pp 176–190
    [Google Scholar]
  12. Spratt B. G., Jobanputra V., Zimmermann W. 1977; Binding of thienamycin and clavulanic acid to the penicillin binding proteins of Escherichia coli K-12. Antimicrobial Agents and Chemotherapy 12:406–409
    [Google Scholar]
  13. Spratt B. G. 1975; Distinct penicillin-binding proteins involved in the division, elongation and shape of Escherichia coli K-12. Proceedings of the National Academy of Sciences of the United States of America 72:2999–3003
    [Google Scholar]
  14. Wise R., Andrews J. M., Patel N. 1981; N-formimidoyl thienamycin, a novel β-lactam: an in-vitro comparison with other β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 7:521–529
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-17-2-159
Loading
/content/journal/jmm/10.1099/00222615-17-2-159
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error